Onconetix (ONCO) Treasury Shares (2022 - 2026)
Onconetix (ONCO) posted quarterly Treasury Shares of $625791.0 for Q1 2026, little changed year-over-year from $625791.0 in Q1 2025, and little changed quarter-over-quarter from $625791.0 in Q4 2025.
Onconetix (ONCO) Treasury Shares (2022 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Treasury Shares for 5 consecutive years, with $625791.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $625791.0; the TTM figure through Mar 2026 stood at $625791.0 (changed 0.0% YoY), while the FY2025 annual figure was $625791.0, changed 0.0% from the prior year.
- Treasury Shares held at $625791.0 in Q1 2026 per ONCO's latest filing, from $625791.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $4.4 million in Q3 2025 and bottomed at -$11493.0 in Q4 2022.
- Historically, Treasury Shares has averaged $652545.5 across 5 years, with a median of $140955.0 in 2024.
- On a YoY basis, Treasury Shares climbed as much as 2351.49% in 2024 and fell as far as 0.0% in 2024.
- Onconetix's Treasury Shares stood at $566810.0 in 2022, then advanced by 10.41% to $625791.0 in 2023, then changed by 0.0% to $625791.0 in 2024, then changed by 0.0% to $625791.0 in 2025, then changed by 0.0% to $625791.0 in 2026.
- Business Quant data shows ONCO's Treasury Shares at $625791.0 in Q1 2026, $625791.0 in Q4 2025, and $625791.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | 625,791.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.21 Mn |
| Jun 30, 2026 | 625,791.00 |
| Jun 30, 2026 | 24.21 Mn |
| Jun 30, 2026 | 625,791.00 |
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 625,791.00 |
| Mar 31, 2026 | 625,791.00 |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 625,791.00 |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 625,791.00 |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 4.38 Mn |
| Sep 30, 2025 | 625,791.00 |
| Sep 30, 2025 | 625,791.00 |
| Jun 30, 2025 | 625,791.00 |
| Jun 30, 2025 | 625,791.00 |
| Jun 30, 2025 | 13,818.00 |
| Jun 30, 2025 | 13,818.00 |